We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
AUM
$156M
AUM Growth
-$6.93M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$88.1M 56.41%
2,111,111
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$58M 37.14%
4,373,178
CYTK icon
3
Cytokinetics
CYTK
$10.8B
$9.96M 6.38%
875,656
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$93K 0.06%
3,700

Similar funds

RP Management's Q3 2019 Portfolio in Review

As of Q3 2019, RP Management held 4 positions worth $156M, down 4.2% from $163M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RP Management's ten largest holdings make up 100% of its $156M portfolio in Q3 2019.
  • RP Management opened 0 new positions and closed 0 in Q3 2019.
  • RP Management's portfolio value fell 4.2% quarter-over-quarter to $156M.

Based on RP Management's 13F filing for Q3 2019, filed 14 Nov 2019.